Case Report
Successful Use of Tocilizumab in a Patient with Coexisting Rheumatoid Arthritis and Ulcerative Colitis
Table 3
Laboratory inflammatory markers at baseline and follow-up period.
| | | Reference range | Baseline | 3 months | 6 months | 12 months | 18 months | 24 months |
| | Haemoglobin (g/L) | 110–150 | 103 | 101 | 110 | 107 | 113 | 110 | | White blood cells (109/L) | 4–11 | 10.8 | 4.9 | 6.3 | 5.2 | 7.1 | 5.7 | | Platelets (109/L) | 150–400 | 553 | 374 | 442 | 439 | 422 | 421 | | Mean cell volume (fL) | 80–100 | 75.3 | 81 | 85.5 | 81.7 | 82.8 | 83.8 | | ESR (mm/h) | 1–20 | 52 | 3 | 7 | 8 | 7 | 11 | | CRP (mg/L) | 0–10 | 2 | <1 | <1 | <1 | <1 | <1 | | Albumin (g/L) | 35–50 | 39 | 38 | 40 | 41 | 39 | 41 | | Weight (kg) | — | 87 | 92 | 94 | 96 | 96 | 96 |
|
|
ESR: Erythrocyte Sedimentation Rate, CRP: C-Reactive Protein.
|
